![](/img/cover-not-exists.png)
Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014
Nathanson, David, Sabale, Ugne, Eriksson, Jan W., Nyström, Thomas, Norhammar, Anna, Olsson, Urban, Bodegård, JohanLanguage:
english
Journal:
PharmacoEconomics - Open
DOI:
10.1007/s41669-017-0063-y
Date:
November, 2017
File:
PDF, 714 KB
english, 2017